HIFU continues to show promise in early PCa

January 1, 2004

Montreal-High-intensity focused ultrasound (HIFU) continues to show promise for the local treatment of prostate cancer. When initiated early in the disease, the minimally invasive procedure offers good efficacy results with little morbidity, according to several European studies presented at the World Congress on Endourology here.